摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2,5-Dimethyl-pyrrol-1-yl)-4-methoxy-phenylamine | 313701-97-2

中文名称
——
中文别名
——
英文名称
3-(2,5-Dimethyl-pyrrol-1-yl)-4-methoxy-phenylamine
英文别名
3-(2,5-dimethylpyrrol-1-yl)-4-methoxyaniline
3-(2,5-Dimethyl-pyrrol-1-yl)-4-methoxy-phenylamine化学式
CAS
313701-97-2
化学式
C13H16N2O
mdl
MFCD01860279
分子量
216.28
InChiKey
VUEBXYJBULSCQG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    398.3±42.0 °C(Predicted)
  • 密度:
    1.10±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    40.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT

文献信息

  • Non-Peptidic Inhibitors of AKAP/PKA Interaction
    申请人:Klussmann Enno
    公开号:US20090176773A1
    公开(公告)日:2009-07-09
    The invention relates to non-peptidic molecules which modulate, especially inhibit, the interaction of protein kinase A (PKA) and A kinase anchor proteins (AKAP) and to a host or target organism that comprises said non-peptidic compounds or recognition molecules directed to said compounds, such as e.g. antibodies or chelating agents. The invention also relates to a pharmaceutical agent, especially for use in the treatment of diseases that are associated with a disturbance of the cAMP signal path, especially insipid diabetes, hypertonia, pancreatic diabetes, duodenal ulcer, asthma, heart failure, obesity, AIDS, edema, hepatic cirrhosis, schizophrenia and others. The invention also relates to the use of the inventive molecules.
查看更多